A detailed history of Verdad Advisers, LP transactions in Viatris Inc stock. As of the latest transaction made, Verdad Advisers, LP holds 60,000 shares of VTRS stock, worth $780,000. This represents 0.93% of its overall portfolio holdings.

Number of Shares
60,000
Previous 75,000 20.0%
Holding current value
$780,000
Previous $797,000 12.67%
% of portfolio
0.93%
Previous 0.92%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $154,800 - $181,950
-15,000 Reduced 20.0%
60,000 $696,000
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $61,985 - $74,415
-5,500 Reduced 6.83%
75,000 $895,000
Q4 2023

Feb 09, 2024

BUY
$8.77 - $10.85 $223,635 - $276,675
25,500 Added 46.36%
80,500 $871,000
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $527,450 - $624,250
55,000 New
55,000 $542,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Verdad Advisers, LP Portfolio

Follow Verdad Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdad Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Verdad Advisers, LP with notifications on news.